Deroy & Devereaux Private Investment Counsel’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,408
| Closed | -$237K | – | 176 |
|
|
2025
Q1 | $237K | Buy |
+3,408
| New | +$237K | 0.01% | 155 |
|
|
2024
Q4 | – | Sell |
-2,700
| Closed | -$321K | – | 176 |
|
|
2024
Q3 | $321K | Hold |
2,700
| – | – | 0.02% | 146 |
|
|
2024
Q2 | $385K | Sell |
2,700
-900
| -25% | -$128K | 0.02% | 138 |
|
|
2024
Q1 | $462K | Sell |
3,600
-563
| -14% | -$72.3K | 0.03% | 136 |
|
|
2023
Q4 | $431K | Sell |
4,163
-2,737
| -40% | -$283K | 0.03% | 137 |
|
|
2023
Q3 | $627K | Sell |
6,900
-2,780
| -29% | -$253K | 0.05% | 114 |
|
|
2023
Q2 | $783K | Buy |
+9,680
| New | +$783K | 0.05% | 107 |
|